Vol 21, No 1s (2018)

Dr. Fakhreddin Jamali: Pharmacist, Pharmaceutical Scientist and Mentor- Dedicated to An Academic Life and Legacy of Fame and Fortune

Dr. Fakhreddin Jamali: Pharmacist, Pharmaceutical Scientist and Mentor- Dedicated to An Academic Life and Legacy of Fame and Fortune

Dr. Fakhreddin Mohammed “Mo” Jamali was originally from Tehran, Iran where he received a Doctor of Pharmacy degree from the University of Tehran in 1969. In 1973 he received a master of science in Pharmaceutics from the Faculty of Pharmaceutical Sciences at the University of British Columbia under the direction of Dr. Alan G. Mitchell , and in 1976 a doctorate in Biopharmaceutics & Pharmacokinetics also from the University of British Columbia under the supervision of Dr. James E. Axelson.  Dr. Jamali is married to Dr. Ella Koshavarz and has one son Vafa. He moved back to Iran an assistant professor from 1976 to 1981 at the University of Tehran, Faculty of Pharmacy. In 1981 he was hired by the University of Alberta, Faculty of Pharmacy & Pharm Sciences as an Assistant Professor. He was promoted  to Associate professor in 1985 and then Professor in 1989. In 2018 he entered into a three year phased retirement plan. Dr. Jamali also served as Associate Dean from 1999 to 2004. He was a Visiting Professor at the Research Institute for Science and Technology of the Tokyo University of Science from 2010  to 2014.

In 1997, Dr. Jamali was founding President of the Canadian Society for Pharmaceutical Sciences. The Canadian Society for Pharmaceutical Sciences (www.cspsCanada.org), is a non-profit organization, whose membership includes scientists worldwide, involved in all aspects of pharmaceutical sciences with affiliations in academia, industry, and government. From 1999 to 2002 Dr. Jamali was a Theme Leader with the Canadian Arthritis Network. In 2002 he founded and became Chief Executive Officer, Chief Scientific Officer, Vice President of Research and Development, and Director of the spin-off corporation EquiTech. This company was designed to commercialize his scientific and discoveries on rapid acting anti-inflammatory and analgesic formulations. From 2007 to 2012 he became the principal investigator at the Centre of Excellence for Gastrointestinal Inflammation and Immunity Research.

 In 1998 he founded and became Editor-in-Chief of the Journal of Pharmacy & Pharmaceutical Sciences (JPPS). This journal was established as an open access fully electronic peer-reviewed journal covering all aspects of pharmacy and pharmaceutical sciences. It was first in the field, and is the official journal of the Canadian Society for Pharmaceutical Sciences (CSPS). JPPS has become a broad-spectrum, peer-reviewed, international pharmaceutical journal circulated electronically via the World Wide Web.  The Journal does not charge fees for neither publishing nor subscription. According to the Journal Citation Reports, the journal had an impact factor of 2.51 during a five year period ending in 2015.  

Dr. Jamali was very prolific in his research endeavours throughout his career.  His interests included the effect of pathophysiological changes on the action and disposition of drugs; stereochemical aspects of drug action and disposition; basic and clinical pharmacology of anti-rheumatic, analgesic and cardiovascular drugs; and the toxicology aspects of non-steroidal anti-inflammatory drugs. He has published over 250 refereed articles, has been an invited speaker at many conferences, and has trained more than 40 graduate students including five professors at the University of Alberta Faculty of Pharmacy & Pharmaceutical Sciences including Dr. Dion Brocks, Dr.  Neal Davies, Dr. Sherif Mahmoud, Dr. Patrick Mayo and Dr. Sharon Mitchell. The majority of Dr. Jamali’s graduate students were members of the undergraduate pharmacokinetics classes in Pharmacy he had taught through his career as an academician, which is a testament to his inspiring teaching style.

For his academic achievements and research, he has received the Canadian Society for Pharmaceutical Sciences Award of Leadership in Pharmaceutical Research and Development in 2001, and the Canadian Arthritis Network Award of Merit in 2004. He was appointed as a Fellow of the American College of Clinical Pharmacology in 1991, the American Association of Pharmaceutical Sciences in 1996, and the Canadian Society for Pharmaceutical Sciences in 2009. He received the McKeen Cattel Memorial Award of the American College of Clinical Pharmacology in 1993, the McNeil Award of the Association of Canadian Faculties of Pharmacy in 1994, the McCalla Professorship of the University of Alberta in 1996, and a Killam Professorship in 2005 among many others.

Dr. Jamali has served as an expert witness, as a consultant or a member of the Board of Directors of many   houses.  He served on the Expert Committee on Drug Quality and Therapeutics with the Province of Alberta between 1992 to 2002. He has been a member of the Health Canada’s Therapeutic Products Program Expert Advisory Committee on Bioavailability and Bioequivalence from 2000 until 2012, and the Expert Advisory Panel on Non-steroidal Anti-inflammatory Drugs from 2002 to 2005.  For his service to the public, he has been honoured with the Alberta Centennial Medal of Outstanding Service in 2005 and the Alberta Pharmacy Centennial Award of Distinction in 2011, the Biruni National Award of Distinguished Scholars, from Shahid Beheshti University of Medical Sciences, Iran, in 2015 and the Canadian Society for Pharmaceutical Sciences Lifetime Achievement Award in 2016.  Dr. Jamali is also an accomplished landscape painter and donates his works to be auctioned in charity events sponsored by various organizations such as the Cancer Board and Arthritis Society.

In closing, we would like to thank Dr. Fakhreddin Jamali, for his tutelage of us all over his career and to each of the authors for dedicating their research to the legacy of our mentor and colleague. Dr. Jamali is a pioneer in pharmacokinetics and pharmacodynamics whose contributions to the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta, nationally, and globally are immense. 

Neal Davies, Ph.D., R.Ph., Dion Brocks, Pharm.D., Ph.D., and Sherif Mahmoud, Ph.D.  READ MORE .... PDF